Amneal Pharmaceuticals, Inc. (AMRX) News
Filter AMRX News Items
AMRX News Results
|Loading, please wait...|
AMRX News Highlights
- For AMRX, its 30 day story count is now at 10.
- Over the past 21 days, the trend for AMRX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about AMRX are DECK, DRUG and ICPT.
Latest AMRX News From Around the Web
Below are the latest news stories about AMNEAL PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMRX as an investment opportunity.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its fourth quarter and full year 2022 financial results on Thursday March 2, 2023, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on March 2, 2023. The financial results and live webcast will be accessible through the Investor Relations section of the Company''s website at https://invest
Intercept reached a settlement with Amneal that delays a generic version of its only product. In response, ICPT stock surged Wednesday.
Amneal Pharmaceuticals Inc. (NYSE:AMRX) price on Friday, January 13, fall -0.45% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.22. A look at the stock’s price movement, the close in the last trading session was $2.23, moving within a range at $2.18 and $2.265. The beta value … Amneal Pharmaceuticals Inc. (NYSE: AMRX): The Metrics That Matter Right Now Read More »
(Bloomberg) -- US health officials have released supplies of the flu drug Tamiflu from a national stockpile as shortages of cold and respiratory medications persist nationwide.Most Read from BloombergElon Musk Fan With 2,900% Gain Sees $1.5 Million Wiped AwayUS Inflation Cools Again, Putting Fed on Track to DownshiftT-Mobile Considers Buying Ryan Reynolds’s Mint MobileThe Document That Separates Biden and TrumpGoogle, Nvidia Express Concerns to FTC About Microsoft’s Activision DealMore than 52,0
Amneal Pharmaceuticals (AMRX) presents at 41st Annual J.P. Morgan Healthcare Conference - Slideshow (NYSE:AMRX)
The following slide deck was published by Amneal Pharmaceuticals, Inc.
Generic drugmaker Amneal Pharmaceuticals (AMRX) reiterated its previously issued financial guidance for the year ending December 31, 2022, on Tuesday. Read the full story here.
Amneal Pharmaceuticals (AMRX) has signed a long-term license agreement with Orion Corporation to commercialize a number of complex generic products.Under the partnership agreement, Orion…
BRIDGEWATER, N.J., January 04, 2023--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ("Amneal" or the "Company") today announced it has signed a long-term license agreement with Orion Corporation (OMXH: ORNBV & ORNAV) to commercialize a number of Amneal’s complex generic products.
The trading price of Amneal Pharmaceuticals Inc. (NYSE:AMRX) closed higher on Friday, December 23, closing at $2.20, 0.92% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $2.17 and $2.25. In examining the 52-week price action we see that the stock hit a 52-week … At What Point In Time Would I Choose To Purchase Amneal Pharmaceuticals Inc. (NYSE: AMRX) Stock? Read More »
Amneal Pharmaceuticals Inc. (NYSE:AMRX) price on Wednesday, December 21, rose 5.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.21. A look at the stock’s price movement, the close in the last trading session was $2.10, moving within a range at $2.12 and $2.21. The beta value … Amneal Pharmaceuticals Inc. (NYSE:AMRX) Shares In 2022: Bullish Prospects Read More »